WaferGen Strikes Pact with Luxembourg's IBBL; Readies European HQ | GenomeWeb

WaferGen BioSystems said today that it inked an agreement with the Integrated BioBank of Luxembourg to co-develop molecular signatures for diagnostic research and commercial applications.

Under the agreement, IBBL will purchase a WaferGen SmartChip Real-Time PCR system and use it to discover and validate gene expression patterns, the company said. In addition, the partners plan to co-develop molecular signatures in cancer and other areas and file for regulatory approval in Europe.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.